Literature DB >> 26223840

Substance P enhances microglial density in the substantia nigra through neurokinin-1 receptor/NADPH oxidase-mediated chemotaxis in mice.

Qingshan Wang1, Esteban Oyarzabal2, Belinda Wilson2, Li Qian2, Jau-Shyong Hong2.   

Abstract

The distribution of microglia varies greatly throughout the brain. The substantia nigra (SN) contains the highest density of microglia among different brain regions. However, the mechanism underlying this uneven distribution remains unclear. Substance P (SP) is a potent proinflammatory neuropeptide with high concentrations in the SN. We recently demonstrated that SP can regulate nigral microglial activity. In the present study, we further investigated the involvement of SP in modulating nigral microglial density in postnatal developing mice. Nigral microglial density was quantified in wild-type (WT) and SP-deficient mice from postnatal day 1 (P1) to P30. SP was detected at high levels in the SN as early as P1 and microglial density did not peak until around P30 in WT mice. SP-deficient mice (TAC1(-/-)) had a significant reduction in nigral microglial density. No differences in the ability of microglia to proliferate were observed between TAC1(-/-) and WT mice, suggesting that SP may alter microglial density through chemotaxic recruitment. SP was confirmed to dose-dependently attract microglia using a trans-well culture system. Mechanistic studies revealed that both the SP receptor neurokinin-1 receptor (NK1R) and the superoxide-producing enzyme NADPH oxidase (NOX2) were necessary for SP-mediated chemotaxis in microglia. Furthermore, genetic ablation and pharmacological inhibition of NK1R or NOX2 attenuated SP-induced microglial migration. Finally, protein kinase Cδ (PKCδ) was recognized to couple SP/NK1R-mediated NOX2 activation. Altogether, we found that SP partly accounts for the increased density of microglia in the SN through chemotaxic recruitment via a novel NK1R-NOX2 axis-mediated pathway.
© 2015 Authors; published by Portland Press Limited.

Entities:  

Keywords:  Parkinson's disease; chemotaxis; microglia distribution

Mesh:

Substances:

Year:  2015        PMID: 26223840      PMCID: PMC5464607          DOI: 10.1042/CS20150008

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  49 in total

1.  Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia.

Authors:  W G Kim; R P Mohney; B Wilson; G H Jeohn; B Liu; J S Hong
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Developmental expression of two CXC chemokines, MIP-2 and KC, and their receptors.

Authors:  J Luan; Y Furuta; J Du; A Richmond
Journal:  Cytokine       Date:  2001-06-07       Impact factor: 3.861

Review 3.  Neuronal 'On' and 'Off' signals control microglia.

Authors:  Knut Biber; Harald Neumann; Kazuhide Inoue; Hendrikus W G M Boddeke
Journal:  Trends Neurosci       Date:  2007-10-24       Impact factor: 13.837

Review 4.  Neuropeptides in the basal ganglia.

Authors:  A M Graybiel
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1986

5.  Regional distribution of substance P in the brain of the rat.

Authors:  M J Brownstein; E A Mroz; J S Kizer; M Palkovits; S E Leeman
Journal:  Brain Res       Date:  1976-11-05       Impact factor: 3.252

Review 6.  The granulocyte-macrophage colony stimulating factors.

Authors:  D Metcalf
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

7.  Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude.

Authors:  M Mittelbronn; K Dietz; H J Schluesener; R Meyermann
Journal:  Acta Neuropathol       Date:  2001-03       Impact factor: 17.088

8.  Distribution of microglia in the postnatal murine nigrostriatal system.

Authors:  Ahmed Sharaf; Kerstin Krieglstein; Björn Spittau
Journal:  Cell Tissue Res       Date:  2012-12-19       Impact factor: 5.249

9.  Differential distribution and activation of microglia in the brain of male C57BL/6J mice.

Authors:  Ting-Ting Yang; Chingju Lin; Chao-Tien Hsu; Tzu-Feng Wang; Fang-Yi Ke; Yu-Min Kuo
Journal:  Brain Struct Funct       Date:  2012-08-12       Impact factor: 3.270

10.  Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases.

Authors:  Xiaowen Liu; Bo Ma; Asrar B Malik; Haiyang Tang; Tao Yang; Bo Sun; Gang Wang; Richard D Minshall; Yan Li; Yong Zhao; Richard D Ye; Jingsong Xu
Journal:  Nat Immunol       Date:  2012-03-25       Impact factor: 25.606

View more
  8 in total

1.  Fasudil Enhances Therapeutic Efficacy of Neural Stem Cells in the Mouse Model of MPTP-Induced Parkinson's Disease.

Authors:  Yan-Hua Li; Jing-Wen Yu; Jian-Yin Xi; Wen-Bo Yu; Jian-Chun Liu; Qing Wang; Li-Juan Song; Ling Feng; Ya-Ping Yan; Guang-Xian Zhang; Bao-Guo Xiao; Cun-Gen Ma
Journal:  Mol Neurobiol       Date:  2016-09-02       Impact factor: 5.590

2.  Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire?

Authors:  Colin Casault; Abdulaziz S Al Sultan; Mohammad Banoei; Philippe Couillard; Andreas Kramer; Brent W Winston
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

Review 3.  Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration.

Authors:  Duraisamy Kempuraj; Ramasamy Thangavel; Govindhasamy P Selvakumar; Smita Zaheer; Mohammad E Ahmed; Sudhanshu P Raikwar; Haris Zahoor; Daniyal Saeed; Prashant A Natteru; Shankar Iyer; Asgar Zaheer
Journal:  Front Cell Neurosci       Date:  2017-07-24       Impact factor: 5.505

4.  Taurine protects dopaminergic neurons in a mouse Parkinson's disease model through inhibition of microglial M1 polarization.

Authors:  Yuning Che; Liyan Hou; Fuqiang Sun; Cong Zhang; Xiaofang Liu; Fengyuan Piao; Dan Zhang; Huihua Li; Qingshan Wang
Journal:  Cell Death Dis       Date:  2018-04-01       Impact factor: 8.469

5.  2,5-Hexanedione induces dopaminergic neurodegeneration through integrin αMβ2/NADPH oxidase axis-mediated microglial activation.

Authors:  Cong Zhang; Liyan Hou; Jie Yang; Yuning Che; Fuqiang Sun; Huihua Li; Qingshan Wang
Journal:  Cell Death Dis       Date:  2018-01-19       Impact factor: 8.469

Review 6.  NADPH oxidases in Parkinson's disease: a systematic review.

Authors:  Karim Belarbi; Elodie Cuvelier; Alain Destée; Bernard Gressier; Marie-Christine Chartier-Harlin
Journal:  Mol Neurodegener       Date:  2017-11-13       Impact factor: 14.195

7.  Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.

Authors:  Duy-Khanh Dang; Eun-Joo Shin; Dae-Joong Kim; Hai-Quyen Tran; Ji Hoon Jeong; Choon-Gon Jang; Seung-Yeol Nah; Jung Hwan Jeong; Jae Kyung Byun; Sung Kwon Ko; Guoying Bing; Jau-Shyong Hong; Hyoung-Chun Kim
Journal:  J Neuroinflammation       Date:  2018-02-21       Impact factor: 8.322

8.  Aprepitant attenuates NLRC4-dependent neuronal pyroptosis via NK1R/PKCδ pathway in a mouse model of intracerebral hemorrhage.

Authors:  Peng Jin; Dongqing Qi; Yuhui Cui; Cameron Lenahan; John H Zhang; Xiaogen Tao; Shuixiang Deng; Jiping Tang
Journal:  J Neuroinflammation       Date:  2022-08-03       Impact factor: 9.587

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.